01 December 2008
Use of an economical wheelchair in India and Peru: impact on health and function
Susan L. ShoreMed Sci Monit 2008; 14(12): PH71-79 :: ID: 869466
Abstract
Background
The overall impact of a wheelchair on its user must be evaluated in light of both benefit and risk. Evaluation should include not only physical function, but also overall quality of life, integration into society, and cost effectiveness. The current study examined the impact of a donated, inexpensively made wheelchair on recipients in 2 different countries.
Material and Method
188 recipients of the Free Wheelchair Mission (FWM) wheelchair in India and Peru were surveyed in their local setting and language by social workers. Results were entered and transferred electronically for analysis.
Results
At the time of the survey, the wheelchairs had been in use for an average of 18 months. 93.1% of recipients used their wheelchair more than 1 hour/day. Receipt and use of the FWM chair resulted in a significant shift toward independent function in 5 of 6 areas drawn from the International Classification of Functioning, Disability, and Health. The greatest maintenance problem was with the tires (19.7%), similar in frequency to reported U.S. users. There was an unexpected 11.7% decrease in the incidence of pressure ulcers with use of the wheelchair, most likely associated with increased mobility. Reported pain levels were not believed by participants to be related to use of the wheelchair. The impact on health and quality of life was generally viewed as positive. Monetary cost of the wheelchair is minimal.
Conclusions
In summary, recipient evaluation of the Free Wheelchair Mission wheelchair in 2 different countries has shown a positive, cost-effective benefit to both health and function without unusual risk.
Keywords: India, Health Status, Child, Preschool, Child, Wheelchairs - economics, Quality of Life, Peru, Aged, 80 and over, Adolescent, Activities of Daily Living
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Database Analysis
Risk Factors of Age-Related Macular Degeneration in a Population-Based Study: Results from SHIP-TREND-1 (St...Med Sci Monit In Press; DOI: 10.12659/MSM.943140
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952